In focus · trending topic

rare disease

31 stories · following the connections

Horizon Pharma plc Partners with Global Genes® to Unite the Rare Disease Community at the Biotechnology Innovation Organization (BIO) International Convention

By Nasdaq OMXJun 20, 2017, 7:00 PM UTC

Horizon Pharma plc Announces Health Canada Approval of PROCYSBI™ (Cysteamine Delayed-Release Capsules) for the Treatment of Nephropathic Cystinosis

By Nasdaq OMXJun 19, 2017, 12:00 PM UTC

Chiasma Reports First Quarter 2017 Results

By Nasdaq OMXMay 5, 2017, 12:02 PM UTC

Selecta Biosciences Announces Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy

By Nasdaq OMXMay 1, 2017, 12:00 PM UTC

aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference

By Nasdaq OMXMar 29, 2017, 1:02 PM UTC

aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference

By Nasdaq OMXMar 29, 2017, 1:02 PM UTC

aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference

By Nasdaq OMXMar 29, 2017, 1:02 PM UTC

Inspire grows online patient community to one million strong

By Nasdaq OMXFeb 8, 2017, 12:01 PM UTC